Maricel M. Apuli's most recent trade in BridgeBio Pharma Inc was a trade of 4,781 Common Stock done at an average price of $51.3 . Disclosure was reported to the exchange on Aug. 16, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| BridgeBio Pharma Inc | Maricel M. Apuli | Chief Accounting Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 51.32 per share. | 16 Aug 2025 | 4,781 | 137,078 (0%) | 0% | 51.3 | 245,361 | Common Stock |
| BridgeBio Pharma Inc | Maricel M. Apuli | Chief Accounting Officer | Sale of securities on an exchange or to another person at price $ 45.44 per share. | 07 Aug 2025 | 1,000 | 141,859 (0%) | 0% | 45.4 | 45,440 | Common Stock |
| BridgeBio Pharma Inc | Maricel M. Apuli | Chief Accounting Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 33.84 per share. | 16 May 2025 | 4,780 | 142,859 (0%) | 0% | 33.8 | 161,755 | Common Stock |
| BridgeBio Pharma Inc | Maricel M. Apuli | Chief Accounting Officer | Sale of securities on an exchange or to another person at price $ 38.51 per share. | 02 May 2025 | 1,026 | 147,639 (0%) | 0% | 38.5 | 39,509 | Common Stock |
| BridgeBio Pharma Inc | Maricel M. Apuli | Chief Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Mar 2025 | 23,660 | 148,665 (0%) | 0% | 0 | Common Stock |